2016 Hematological Malignancies

• High-dose therapy followed by autologous stem cell transplantation (ASCT) has been clearly identified as a reference treatment in relapsing/refractory patients compared to standard chemotherapy • However, many questions still remain: definition of subgroups with different risk

type and number of salvage chemotherapy cycles use of metabolic imaging in response definition place of double ASCT need to consider allogeneic transplantation in selected patients role of radiotherapy